Voyager Therapeutics Inc. (VYGR)
NASDAQ: VYGR
· Real-Time Price · USD
3.73
0.01 (0.27%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.83%
After-hours: Aug 15, 2025, 07:35 PM EDT
Voyager Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 42.58M | 66.96M | 80M | 163.78M | 143.77M | 119.04M | 250.01M | 118.86M | 155.33M | 151.19M | 1.37M | 70.53M | 30.93M | 31.57M | 37.41M | 15.88M | 132.24M | 159.56M |
Cost of Revenue | n/a | 34.45M | 35.65M | 36.98M | 37.93M | 4.56M | 21.93M | 21.43M | 21.83M | 21.95M | 6.19M | 19.38M | 35.95M | 54.25M | 73.78M | 81.76M | 88.89M | 98.8M |
Gross Profit | 42.58M | 32.51M | 44.35M | 126.8M | 105.84M | 114.48M | 228.07M | 97.43M | 133.5M | 129.24M | -4.82M | 51.15M | -5.03M | -22.68M | -36.37M | -65.88M | 43.35M | 60.76M |
Operating Income | -123.4M | -101.8M | -83.29M | 9.07M | -6.65M | -17.05M | 122.01M | 43.39M | 87.34M | 93.4M | -50.84M | -20.57M | -60.16M | -69.38M | -73.62M | -103.05M | 6.62M | 26.23M |
Interest Income | 10.7M | 12.76M | 14.33M | 17.49M | 16.34M | 14.72M | 11.72M | 9.54M | 6.66M | 3.6M | 1.77M | 795K | 371K | 200K | 188K | 269K | 402K | 700K |
Pretax Income | -107.25M | -84M | -64.34M | 26.78M | 9.71M | -2.33M | 133.74M | 52.91M | 96.61M | 99.67M | -46.39M | -17.07M | -59.84M | -70.87M | -71.2M | -92.83M | 17.92M | 39.35M |
Net Income | -107.93M | -84.69M | -65M | 25.88M | 9.02M | -3.04M | 132.33M | 52.31M | 95.83M | 99.17M | -46.16M | -16.82M | -59.58M | -70.84M | -71.2M | -92.83M | 17.92M | 39.35M |
Selling & General & Admin | 37.3M | 36.95M | 35.92M | 37.17M | 37.26M | 35.4M | 35.82M | 34.04M | 33.09M | 32.35M | 30.98M | 30.87M | 32.28M | 35.16M | 37.25M | 37.16M | 36.73M | 34.53M |
Research & Development | 128.68M | 131.8M | 126.17M | 115.01M | 110.63M | 98.17M | 90.84M | 80.97M | 74.44M | 64.98M | 60.76M | 60.23M | 58.81M | 65.79M | 73.78M | 81.76M | 88.89M | 98.8M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 956K | 3.59M | 3.65M | 3.65M | 2.7M | -45K | -1.69M | 2.23M | 9.95M | 10.89M | 12.43M |
Operating Expenses | 165.98M | 168.75M | 162.09M | 152.18M | 147.89M | 133.57M | 126.66M | 115.01M | 107.53M | 97.33M | 91.74M | 91.1M | 91.09M | 100.95M | 111.03M | 118.93M | 125.61M | 133.33M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 997K | 997K | 997K | 997K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 165.98M | 168.75M | 163.29M | 154.71M | 150.42M | 136.1M | 127.99M | 115.01M | 107.53M | 97.33M | 91.74M | 91.1M | 91.09M | 100.95M | 111.03M | 118.93M | 125.61M | 133.33M |
Income Tax Expense | 679K | 688K | 665K | 903K | 683K | 718K | 1.41M | 602K | 779K | 501K | -234K | -1.73M | -1.85M | -1.68M | -1.67M | -269K | -402K | -354K |
Shares Outstanding (Basic) | 58.67M | 58.35M | 57.97M | 57.85M | 57.72M | 57.12M | 43.98M | 43.86M | 43.52M | 40.63M | 38.55M | 38.51M | 38.17M | 38.05M | 37.8M | 37.52M | 37.58M | 37.33M |
Shares Outstanding (Diluted) | 58.67M | 58.35M | 57.97M | 57.85M | 57.72M | 57.12M | 45.08M | 43.86M | 43.52M | 42.16M | 38.55M | 39.57M | 38.3M | 38.05M | 37.8M | 37.78M | 37.58M | 37.5M |
EPS (Basic) | -1.85 | -1.46 | -1.13 | 0.74 | 0.31 | -0.02 | 3.23 | 1.34 | 2.39 | 2.41 | -1.2 | -0.44 | -1.57 | -1.88 | -1.9 | -2.48 | 0.49 | 1.06 |
EPS (Diluted) | -1.85 | -1.46 | -1.13 | 0.71 | 0.28 | -0.05 | 3.09 | 1.23 | 2.27 | 2.29 | -1.21 | -0.45 | -1.57 | -1.88 | -1.9 | -2.48 | 0.46 | 1.03 |
EBITDA | -119.17M | -97.25M | -78.56M | 14.13M | -1.78M | -12.49M | 126.45M | 47.33M | 91.67M | 97.85M | -44.65M | -13.73M | -53.44M | -62.68M | -68.45M | -98.38M | 11.13M | 30.48M |
EBIT | -123.4M | -101.8M | -83.29M | 12.23M | -3.5M | -13.9M | 125.17M | 43.39M | 90.52M | 96.58M | -47.66M | -17.39M | -60.16M | -69.38M | -73.62M | -103.05M | 7.71M | 27.31M |
Depreciation & Amortization | 4.22M | 4.55M | 4.73M | 5.05M | 4.87M | 4.56M | 4.44M | 3.94M | 4.34M | 4.45M | 6.19M | 6.84M | 6.72M | 6.7M | 5.17M | 4.67M | 4.51M | 4.25M |